Dawn Carter Bir - 21 Oct 2025 Form 4 Insider Report for CASSAVA SCIENCES INC (SAVA)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
22 Oct 2025, 18:15:16 UTC
Prior SEC filing
09 Jun 2025
Next SEC filing
18 May 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Eric J. Schoen by Power of Attorney

Key filing fact

Dawn Carter Bir filed Form 4 for CASSAVA SCIENCES INC (SAVA) on 22 Oct 2025.

Key facts

  • This page summarizes Dawn Carter Bir's Form 4 filing for CASSAVA SCIENCES INC (SAVA).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 22 Oct 2025, 18:15.

Change

  • Previous filing in this sequence was filed on 09 Jun 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001688712 Primary reporting owner

Bir Dawn Carter

Relationship
Director
Address
6801 N CAPITAL OF TEXAS HWY, BLDG 1, SUITE 300, AUSTIN
Signature
/s/ Eric J. Schoen by Power of Attorney
Signature date
22 Oct 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

SAVA transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
$0
Shares
+53,000
Change %
Price
$0.000000
Shares after
53,000
Date
21 Oct 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
53,000
Exercise price
$3.98
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The stock option vests over three (3) years at a rate of 1/36th each month.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .